ONL Therapeutics

Manufacturing · Michigan, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

524 S Main St Ste 110, Ann Arbor, Michig...

Phone Number

(734) 412-8787

Revenue

<$5 Million

Industry

Manufacturing Pharmaceuticals

About ONL Therapeutics

ONL Therapeutics is a clinical-stage biopharmaceutical company focused on developing innovative therapeutics to protect and enhance vision for patients suffering from various retinal diseases. Their lead candidate, xelafaslatide, is a first-in-class small peptide undergoing clinical trials for conditions like geographic atrophy associated with dry AMD. The company is pioneering a novel approach to prevent the death of key retinal cells through Fas-mediated signaling, addressing a significant medical need in vision preservation. ONL Therapeutics aims to provide new solutions for millions of individuals facing limited options for vision-related issues.Explore more
ONL Therapeutics's Social MediaSIC Code 28,283NAICS Code 32,325Show more

ONL Therapeutics Org Chart

DE
United States flag for contact location.

President & Chief Executive Officer

Flame icon indicating likelihood to engage via phone.PhoneFlame icon indicating likelihood to engage via email.Email
Connie Chang, Chief Operating Officer at ONL Therapeutics
United States flag for contact location.

Chief Operating Officer

Flame icon indicating likelihood to engage via phone.PhoneFlame icon indicating likelihood to engage via email.Email

PhoneEmail
Get the full picture
Sign in to uncover key details.
LJ
United States flag for contact location.

Senior Vice President, Operations

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Compare Similar Companies to ONL Therapeutics

Compare insights from companies similar to ONL Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

ONL Therapeutics

<$5M
11-50
Private
$132.6M
2011
DE
David EspositoPresident & CEO
$5.1M
11-50
Private
<$5M
2003
YG
Ya GaoRegulatory Affairs Associate
$5M
11-50
Private
$91.4M
1999
MR
Mo RyanTerritory Manager
11-50
Public
$166.9M
2004
Illustration of an envelope

ONL Therapeutics Tech Stack

A closer look at the technologies used by ONL Therapeutics

Top Manufacturing Companies

Frequently Asked Questions Regarding ONL Therapeutics

What is ONL Therapeutics's official website?
ONL Therapeutics's official website is www.onltherapeutics.com
What is ONL Therapeutics's Revenue?
ONL Therapeutics's revenue is <$5 Million
What is ONL Therapeutics's SIC code?
ONL Therapeutics's SIC: 28,283
What is ONL Therapeutics's NAICS code?
ONL Therapeutics's NAICS: 32,325
How many employees does ONL Therapeutics have?
ONL Therapeutics has 11-50 employees
What industry does ONL Therapeutics belong to?
ONL Therapeutics is in the industry of: Manufacturing, Pharmaceuticals
What is ONL Therapeutics competition?
ONL Therapeutics top competitors include: Novelmed Therapeutics, Novasys Medical, Relmada Therapeutics
What technology does ONL Therapeutics use?
Some of the popular technologies that ONL Therapeutics uses are: Hosting.com (formerly A2 Hosting), WordPress.org, PHP, AppRiver
How do I contact ONL Therapeutics?
ONL Therapeutics contact info: Phone number: (734) 412-8787 Website: www.onltherapeutics.com
What does ONL Therapeutics do?

ONL Therapeutics is a clinical-stage biopharmaceutical company focused on developing innovative therapeutics to protect and enhance vision for patients suffering from various retinal diseases. Their lead candidate, xelafaslatide, is a first-in-class small peptide undergoing clinical trials for conditions like geographic atrophy associated with dry... AMD. The company is pioneering a novel approach to prevent the death of key retinal cells through Fas-mediated signaling, addressing a significant medical need in vision preservation. ONL Therapeutics aims to provide new solutions for millions of individuals facing limited options for vision-related issues.Read More

What are ONL Therapeutics social media links?
ONL Therapeutics Linkedin page ONL Therapeutics Twitter page ONL Therapeutics Facebook page
Who invested in ONL Therapeutics?
ONL Therapeutics has 20 investors including ExSight Ventures, Johnson & Johnson Innovation, Kaitai Capital and Michigan Capital Network.
Is ONL Therapeutics a public company?
ONL Therapeutics is private company therefore does not currently have an official ticker symbol
See more information about ONL Therapeutics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.